DOCS Stock Price Today (September 2026) — Doximity, Inc. Analysis & Key Metrics 2026-09-03
Doximity, Inc. (DOCS) is trading at $27.10, up 2.96% today (as of September 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $29.78 (9.9% upside).
- Volatility remains elevated (28.79% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (7.30% YoY) alongside significant competitive pressures.
DOCS Stock Analysis: Key Metrics & Valuation (September 2026)
Concise, actionable data for investors
Doximity, Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $4.09B
P/E Ratio
Forward P/E: 17.24
Revenue Growth
Year over Year
Analyst Target
+9.9% upside potential
Key Investor Questions About DOCS
What investors need to know before buying
Based on current market data, DOCS presents a neutral technical setup with looking solid fundamentals.
- Technicals say: Neutral (RSI 64.65)
- Fundamentals say: Looking solid (debt and growth supportive)
DOCS's growth trajectory depends on its ability to expand within the Health Information Services sector while managing margin pressures.
- Future growth will depend on performance in core Health Information Services operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for DOCS investors include debt exposure and competitive dynamics in the Health Information Services industry.
- $9.67M in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Health Information Services.
52-Week Trading Range
Over the past year, DOCS stock traded between $17.15 and $76.51—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 28.79% annualized volatility and β=1.02, the stock exhibits moderate correlation to market moves—making DOCS suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Since March 2026, Doximity has been in a holding pattern, posting a small return of 2.8% while floating around $26.41. The stock also fell short of the S&P 500’s 12.1% gain during that period.
Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intelligence is driving growth across enterprise software rather than threatening legacy business models.
1 Software Stock on Our Buy List and 2 Facing Challenges
Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with explosive earnings growth, and the upward trend shows no signs of stopping as the industry has posted a 44.6% gain over the past six months, beating the S&P 500 by 32.9 percentage points.
Reasons to Retain Doximity Stock in Your Portfolio for Now
DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?
Hims & Hers' rally is fueled by branded weight-loss growth, international expansion, AI efficiencies and a broader specialty portfolio.
Doximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings
Doximity stock has had a difficult five year stretch, with shareholders seeing the share price decline 71.8%, even as recent AI driven products have drawn fresh attention. At the current price near US$24.94, the key issue is whether the latest enthusiasm lines up with what the intrinsic value and market based checks say about Doximity. Over five years, the share price decline of 71.8% points to investors reassessing what they are willing to pay for Doximity. Growth expectations around...
Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings Guidance
Doximity (DOCS) is back in focus after its latest quarterly report showed higher sales, raised full year revenue guidance, and continued margin pressure tied to heavier spending on AI tools. See our latest analysis for Doximity. At a share price of US$24.94, Doximity has seen a 30 day share price return of 15.89% and a 90 day share price return of 25.58%. However, the year to date share price return is down 42.39% and the 1 year total shareholder return is down 60.79%. This points to...
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know
This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.
What Investors Should Know of This Doximity Officer's Latest Insider Transaction
Sitaram's sale was driven by tax obligations from option exercises and RSU vesting, not a shift in conviction.
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors
Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.
Explore More Analysis for DOCS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Frequently Asked Questions
Common investor questions about Doximity, Inc.
Doximity, Inc. (DOCS) is currently trading at $27.10. The RSI (14-day) is at 64.6, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $29.78 implies 9.9% upside from current levels. Volatility is moderate at 28.8% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Doximity, Inc. (DOCS): The trailing P/E ratio is 32.26, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 17.24, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 0.59, below 1.0, which generally indicates the stock is undervalued relative to its growth rate. Price-to-Book is 5.32. Price-to-Sales is 5.26. Valuation should be compared to Health Information Services industry peers for context, as different sectors trade at different multiples.
Based on 18 analysts covering DOCS, the consensus price target is $29.78. This represents a 9.9% upside from the current price of $27.10. The range spans from a low target of $18.00 to a high target of $47.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Doximity, Inc. (DOCS) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Doximity, Inc. (DOCS) investors include: 1. Moderate volatility (28.8% annualized)—price swings are notable. 2. Elevated short interest (14.8% of float) suggests significant bearish sentiment. 3. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 4. Health Information Services sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Doximity, Inc.'s (DOCS) current debt and financial health profile: Total debt stands at $9.67M. The debt-to-equity ratio is 1.06, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 6.08, indicating strong short-term liquidity. The quick ratio is 5.80. The company holds $687.79M in cash and equivalents. Free cash flow is positive at $239.70M, providing a cushion for debt servicing and shareholder returns.